Symbol="KALA"
AssetType="Common Stock"
Name="Kala Pharmaceuticals Inc"
Description="Kala Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development and commercialization of therapies using its proprietary nanoparticle-based mucus penetrating particle (MPP) technology for the treatment of eye diseases. The company is headquartered in Watertown, Massachusetts."
CIK="1479419"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="100 BEAVER STREET, SUITE 201, WALTHAM, MA, US"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="35140400"
EBITDA="-42606000"
PERatio="29.4"
PEGRatio="0"
BookValue="6.89"
DividendPerShare="0"
DividendYield="0"
EPS="0.47"
RevenuePerShareTTM="0.222"
ProfitMargin="0"
OperatingMarginTTM="-102.36"
ReturnOnAssetsTTM="-0.355"
ReturnOnEquityTTM="-2.898"
RevenueTTM="420000"
GrossProfitTTM="1332000"
DilutedEPSTTM="0.47"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="-1"
AnalystTargetPrice="30"
TrailingPE="29.4"
ForwardPE="-"
PriceToSalesRatioTTM="1.157"
PriceToBookRatio="2.944"
EVToRevenue="0.0421"
EVToEBITDA="0.0299"
Beta="-1.53"
num_52WeekHigh="56.72"
num_52WeekLow="3.544"
num_50DayMovingAverage="14.53"
num_200DayMovingAverage="14.07"
SharesOutstanding="2542700"
DividendDate="None"
ExDividendDate="None"
symbol="KALA"
open="13.40"
high="14.21"
low="13.21"
price="13.82"
volume="49346.00"
latest_trading_day="2023-08-21"
previous_close="13.65"
change="0.17"
change_percent="1.2454%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="45"
trend_strength="Strong Trend"
buying_signal="Strong Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="55"
Volume_recent_avg="93149"
Change_recent_avg="0.01"
Delta_recent_avg="1.02"
Variance_recent_avg="0.51"
Change_ratio_recent_avg="-0.06"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="55"
Aroon_momentum_negative="45"
image_negative_thumbnail_id_1="139"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0037.jpeg"
image_negative_thumbnail_id_2="499"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0106.jpeg"
image_neutral_thumbnail_id_1="578"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0021.jpeg"
image_neutral_thumbnail_id_2="543"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0056.jpeg"
image_positive_thumbnail_id_1="989"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0151.jpeg"
image_positive_thumbnail_id_2="599"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0109.jpeg"
image_professor_thumbnail_id_1="1198"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0032.jpeg"
image_professor_thumbnail_id_2="1197"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0031.jpeg"
